Skip to main content

Table 2 Evoked potentials associated with the SSAS

From: Clinical application of somatosensory amplification in psychosomatic medicine

EEG variables Means (S.D.) and coefficienta to SSAS (signed)
  Latency, msec Amplitude, μV
Somatosensory evoked potential     
   N9 9.5 (0.7) (+) 5.1 (2.3) (-)
   N9–N13 3.8 (0.6) (+) 1.8 (0.8) (-)
   N13–N20 5.8 (1.2) (-) 1.1 (0.7) (+)
   N20–P23 3.3 (1.2) (-) 1.2 (0.7) (+)
Auditory evoked potential     
   I 1.5 (0.1) (+) 0.2 (0.1) (-)
   III 3.7 (0.1) (-) 0.3 (0.1) (-)
   V 5.6 (0.2) (+) 0.6 (1.3) (-)*
Visual evoked potential     
   N75 73.2 (10.1) (-) 3.3 (2.3) (-)
   P100 103.1 (10.3) (+)* 5.9 (2.3) (-)
   N145 138.0 (15.9) (-) 3.3 (1.7) (-)
Event-related potential     
   N100 111.5 (40.6) (+) 4.2 (2.1) (-)
   P200 180.3 (45.2) (+)** 2.9 (1.6) (+)
   N200 248.1 (51.7) (+) 4.4 (2.9) (-)
   P300 333.6 (70.7) (+) 2.7 (1.8) (-)**
  1. a The coefficient refers to the partial Pearson's correlation coefficient adjusted for the Toronto alexithymia scale scores and depression and tension-anxiety scores on the Profile of Mood States. A positive (negative) mark indicates a positive (negative) coefficient; *p < 0.10 and **p < 0.05.